Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2014 Aug;42(8):1573-93.
doi: 10.1007/s10439-014-1032-6. Epub 2014 May 15.

Closed-loop brain-machine-body interfaces for noninvasive rehabilitation of movement disorders

Affiliations
Review

Closed-loop brain-machine-body interfaces for noninvasive rehabilitation of movement disorders

Frédéric D Broccard et al. Ann Biomed Eng. 2014 Aug.

Abstract

Traditional approaches for neurological rehabilitation of patients affected with movement disorders, such as Parkinson's disease (PD), dystonia, and essential tremor (ET) consist mainly of oral medication, physical therapy, and botulinum toxin injections. Recently, the more invasive method of deep brain stimulation (DBS) showed significant improvement of the physical symptoms associated with these disorders. In the past several years, the adoption of feedback control theory helped DBS protocols to take into account the progressive and dynamic nature of these neurological movement disorders that had largely been ignored so far. As a result, a more efficient and effective management of PD cardinal symptoms has emerged. In this paper, we review closed-loop systems for rehabilitation of movement disorders, focusing on PD, for which several invasive and noninvasive methods have been developed during the last decade, reducing the complications and side effects associated with traditional rehabilitation approaches and paving the way for tailored individual therapeutics. We then present a novel, transformative, noninvasive closed-loop framework based on force neurofeedback and discuss several future developments of closed-loop systems that might bring us closer to individualized solutions for neurological rehabilitation of movement disorders.

PubMed Disclaimer

Figures

Figure 1
Figure 1
A system framework towards neurofeedback noninvasive rehabilitation of movement disorders by means of closed-loop brain-machine-body interfaces. Signals from the central (CNS) and peripheral (PNS) nervous system are recorded and monitored by the mobile brain/body imaging (MoBI, [95]) and motion capture (MoCap) systems, respectively. Electroencephalography (EEG), electromyography (EMG), kinetics and eye-tracking signals provide inputs to the MIMO (multiple-input and multiple-output) module. The MIMO module outputs force feedback to external devices (haptic robots, cyber glove or exoskeleton) that is sensed by the brain via the PNS. The force is generated by adaptive control of the MIMO module's parameters (θ). The fitness function Q from the METRIC module is computed from the EEG, EMG and force signals, and outputs PD markers to the MIMO module. Oblique gray arrows indicate adaptive processes. Dashed lines indicate optional elements. Once tested and validated in the neurofeedback framework by comparing the forward modeling (see text for details) of its outputs with those monitored by MoBI and MoCap, the thalamocortical/BG model can be used as a model-based module providing additional inputs to the METRIC module helping constructing a better fitness function Q. Red and blue lines indicate information from the PNS and the CNS, respectively.
Figure 2
Figure 2
(a) Mobile brain/body imaging (MoBI) setup for a participant on a treadmill and performing a visual oddball response task during standing, slow walking and fast walking. (b) Grand-average event-related potentials (ERPs) during standing, slow and fast walking. The ERP time course is represented in red for the target and blue for the non-target. Scalp maps show the grand-average ERP scalp distributions at 100, 150 and 400 ms after onsets of target (upper row) and non-target (lower row) stimuli. White dots indicate the location of electrode Pz. Note the scalp map similarities across conditions. Adapted from [97].
Figure 3
Figure 3
(a) Participants are wearing a motion capture suit with infrared (IR) emitters and a high-density EEG cap (128 channels), allowing to monitor simultaneously the body kinematics and brain dynamics, respectively, during a hand mirroring task (one participant was instructed to follow the hand's movement of another participant). The position of the IR emitters is captured at 480 Hz by 12 cameras in the room. (b) Identification and localization of functionally distinct sources by independent component analysis (ICA) during a 3D object orienting task. The participant was cued to look forward, point to, or walk to and point to one of several objects present in the room. ICA allowed to separate the EEG data into a number of temporally and functionally independent sources from the brain and body that may then be localized (middle). Top left, an independent component (IC) source localized to in or near left precentral gyrus (BA 6) shows a decrease of high-beta band activity following cues to point to objects on the left or right. Bottom left, another right middle frontal (BA 6) IC source exhibits mean theta- and beta-band increases followed by mu- and beta-band decreases during and after visual orienting to the left or right. Top right, an IC source accounting for activity in a left neck muscle produces a burst of broadband EMG activity during left pointing movements and while maintaining a right pointing stance. Bottom right, a right neck muscle IC source exhibits an EMG increase during right head turns and during maintenance of left-looking head position. Data collected with a 256-channel EEG system. BA, Brodmann Area. Panel (b) modified from [95].
Figure 4
Figure 4
Eye-hand coordination and corrective response control in PD during a reach-to-grasp task. (a) Experimental setup using eye-tracking hardware, haptic robots, EEG and a virtual reality environment. Participants reached to and grasped a rectangular object displayed on the screen with the thumb and index finger of their right hand fixed into thimble gimbals affixed to the left and right robot, respectively. Participants had haptic as well as visual feedback of the dock so that they felt their hands resting on a solid surface. The object's orientation was perturbed on 33% of the trials by rotating it 90 degrees in the frontal plane, thereby making the object appear horizontal. The perturbation occurred at a randomly jittered distance of 20-40% between the starting dock and the front of the object. The goal of the task remained the same regardless of the object orientation: to grasp along the left and right sides of the object. Therefore, participants had to adjust their grasp dynamically to a larger precision grip during perturbation trials. (b) Top view of reach to grasping movements in one representative PD patient on and off medications (PD ON vs. PD OFF) and his/her age-matched control. For the blocked vision conditions, visual feedback of finger position was removed during the first ~2/3rds of the reach, as depicted by a dark gray line. The average peak aperture (PA) and peak tangential velocity (PV) are marked along the thumb and index finger for each of the representative subjects during the unperturbed full vision condition. EEG data not shown. Adapted from [105].
Figure 5
Figure 5
3D visualization of brain activity in real-time with a wireless EEG headset. (a) Real-time data processing pipeline using a Cognionics 64-channel system with flexible active dry electrodes, and the open source EEGLAB [64] extensions SIFT [65] and BCILAB [67]. (b) Temporal snapshot of online reconstructed source networks with Partial Direct Coherence (PDC estimator) displayed with the BrainMovie3D visualizer for simulated data. Node size indicates outflow (net influence of a source on all other sources). Cortical surface are colored according to their AAL atlas label (90 regions). Adapted from [113].

Similar articles

Cited by

References

    1. Lyons KE, Pahwa R. Pharmacotherapy of essential tremor: an overview of existing and upcoming agents. CNS Drug. 2008;22:1037–1045. - PubMed
    1. Thenganatt MA, Fahn S. Botulinum toxin for the treatment of movement disorders. Curr. Neurol. Neurosci. 2012;12:399–409. - PubMed
    1. Worth PF. How to treat Parkinson's disease in 2013. Clin. Med. 2013;13:93–96. - PMC - PubMed
    1. Rascol O, Payoux P, Ory F, Ferreira JJ, Brefel-Courbon C, Montastruc JL. Limitations of current Parkinson's disease therapy. Ann. Neurol. 2003;53(Supp.3):S3–S12. - PubMed
    1. Raja M, Bentivoglio AR. Impulsive and compulsive behaviors during dopamine replacement treatment in Parkinson's disease and other disorders. Curr. Drug Saf. 2012;7:63–75. - PubMed

Publication types